IFNB1 and glioblastoma: Therefore, in the current study we first sought to test the intracranial AAVrh8‐IFN‐β‐based therapeutic approach in a highly invasive human glioblastoma model (GBM8) (Wakimoto et al., 2009) implanted in athymic nude mice.